CrowdStrike Cyber Superintelligence Lab

CrowdStrike

CrowdStrike describes its Cyber Superintelligence Lab as the first frontier AI research organization built for cyber defense and AI safety.

CrowdStrike Cyber Superintelligence Lab is listed on TechiSeek as Research from CrowdStrike. The advertiser destination website is crowdstrike.com. First listed on 12 September 2026. This TechiSeek page is the indexable listing record; visiting the advertiser site uses a separate outbound link.

Visit website

Related listings

• CrowdStrike Falcon Next-Gen SIEM Demo Drill Down (CrowdStrike)
  CrowdStrike presents an adversary-driven detection demo for Falcon Next-Gen SIEM, showing how the platform surfaces and investigates threat…
• Falcon Cloud Security Detection and Response Demo (CrowdStrike)
  A CrowdStrike demo on Falcon Cloud Security covering cloud misconfigurations and vulnerabilities, with cloud detection and response shown a…
• Falcon Next-Gen SIEM AI-Assisted Investigation Demo (CrowdStrike)
  A CrowdStrike demo drill-down on AI-assisted investigation in Falcon Next-Gen SIEM, showing how the platform supports analysts working thro…
• Falcon Next-Gen SIEM Adversary-Driven Detection Demo (CrowdStrike)
  A CrowdStrike demo showing how Falcon Next-Gen SIEM detection and threat intelligence provide investigative detail and context so teams can…
• Fal.Con 2026 Europe Security Conference (CrowdStrike)
  CrowdStrike's Fal.Con 2026 Europe event examines how AI is reshaping both the threat landscape and enterprise priorities, with guidance on…
• CrowdTour Cybersecurity Roadshow (CrowdStrike)
  CrowdStrike's global cybersecurity roadshow brings defenders together for sessions on current threats and defensive practices in cities aro…
• CrowdStrike Named Leader in Forrester Wave for IR (CrowdStrike)
  CrowdStrike was named a Leader in The Forrester Wave: Cybersecurity Incident Response Services, Q2 2024, an analyst evaluation of incident…
• Acumen removes missed renewals with HubSpot Revenue Hub (HubSpot)
  HubSpot case study on how Acumen, which since 2016 has helped biopharma companies turn scientific data into regulatory documents, used Reve…